Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corticotropin-releasing factor 2 receptor (CRHR2) is a type 2 G protein-coupled receptor activated by urocortins II & III and corticotropin-releasing hormone. It plays a crucial role in stress adaptation, cardiovascular regulation, angiogenesis, and metabolic processes. Dysregulation of CRHR2 is implicated in various conditions including anxiety, PTSD, heart failure, and cancer, making it a potential therapeutic target.
Activation of adenylate cyclase via Gαs, leading to increased intracellular cAMP
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-releasing factor 2 receptor (CRHR2).